Metrics
- Price
- $34.22
- Market Cap $M
- N/A
- Rel Volume
- 0.96
- Vol Up 2W
- 44.40%
- Vol Trend 2W
- -67.20%
- 1D
- +2.78%
- 1W
- +0.34%
- 1M
- +16.93%
- 1M Slope
- +14.97%
- 6M Range
- 44.07%
- Score
- 69.7
- Sharp
- 0.7
Volume
Profile
Genmab develops antibody therapeutics for cancer and other serious diseases, partnering with pharmaceutical companies to advance and commercialize its drug candidates.
Biotech
Pharmaceuticals